SCHEMBL528608

SCHEMBL528608

CC(=CO[Si](C)(C)C)C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.32
AKR1C3 P42330 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1570545 1.00 PTGS1 (0.32) PTGS1AKR1C3
SCHEMBL10608638 0.82
SCHEMBL10608647 0.82
SCHEMBL10376016 0.77
SCHEMBL1865885 0.73 PTGS1 (0.37) PTGS1AKR1C3
SCHEMBL1865884 0.73 PTGS1 (0.37) PTGS1AKR1C3
SCHEMBL10523584 0.72
SCHEMBL448298 0.71
SCHEMBL167103 0.70
SCHEMBL5998620 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118202009-A Ink applicator 墨水盒墨水公司 2024-06-14 CN claimed
CN-118078686-A Sun-screening pigment cream and preparation method and application thereof 山东花物堂生物科技有限公司 2024-05-28 CN claimed
EP-3831357-B1 COSMETIC COMPOSITION WITH METALLIC EFFECT CHANEL PARFUMS BEAUTE (FR) 2024-04-17 EP claimed
CN-116997315-A Cosmetic composition for improving skin and use method thereof 莱雅公司 2023-11-03 CN claimed
CN-116322621-A Semi-permanent tattoo 墨水盒墨水公司 2023-06-23 CN claimed
CN-115996980-A Semi-permanent tattoo 墨水盒墨水公司 2023-04-21 CN claimed
EP-3554465-B1 COSMETIC PREPARATION IN GEL FORM SCHWAN STABILO COSMETICS GMBH & CO KG (DE) 2022-09-28 EP claimed
WO-2022133733-A1 COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS L'OREAL (FR) 2022-06-30 WO claimed
US-20210169776-A1 COSMETIC COMPOSITION WITH A METALLIC EFFECT CHANEL PARFUMS BEAUTE (FR) 2021-06-10 US claimed
EP-3831357-A1 COSMETIC COMPOSITION WITH METALLIC EFFECT Chanel Parfums Beauté (FR) 2021-06-09 EP claimed
WO-2018096262-A1 FILM-FORMING COMPOSITION BASED ON PULLULAN, AND USES THEREOF IN COSMETIC COMPOSITIONS FOR MAKING UP AND/OR CARING FOR KERATIN MATERIALS, THE SKIN AND THE LIPS LVMH RECHERCHE (FR) 2018-05-31 WO claimed
EP-2306968-B1 COSMETIC COMPOSITION CONTAINING A SILICONE ACRYLATE AND A POLYESTER WAX CHANEL PARFUMS BEAUTÉ (FR) 2016-12-07 EP claimed
EP-2165719-B1 Wound care preparation with reduced skin irritations BEIERSDORF AG (DE) 2015-07-08 EP claimed
US-8871229-B2 Cosmetic composition for long-wearing properties L'OREAL (FR) 2014-10-28 US claimed
US-20130224130-A1 COSMETIC COMPOSITION FOR LONG-WEARING PROPERTIES L'OREAL S.A. (FR) 2013-08-29 US claimed
CN-119730834-A Personal care compositions containing spherical silicone elastomer fine particles 迈图高新材料公司 2025-03-28 CN disclosed
CN-114845695-B External skin preparation composition 花王株式会社 2024-12-24 CN disclosed
EP-0452098-A2 Silicone-containing block copolymers and macromonomers E.I. du Pont de Nemours and Company (US) 1991-10-16 EP disclosed
US-5057578-A Contact lenses E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-15 US disclosed
US-5019628-A Silicone containing acrylic star polymers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130224130-A1 COSMETIC COMPOSITION FOR LONG-WEARING PROPERTIES CUTA, QARS1, KRT18 PTGS1 1380/4885AKR1C3 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.